(19)

(11)

EP 4 823 467 A1

(12)

(43) Date of publication: 21.10.2026 Bulletin 2026/43 (21) Application number: 24838089.1 (22) Date of filing: 06.12.2024

(51) International Patent Classification (IPC):  A61B 17/34(2006.01) A61F 2/24(2006.01) A61B 90/00(2016.01) A61B 17/32(2006.01) A61B 17/22(2006.01) (52) Cooperative Patent Classification (CPC): A61B 2017/00783; A61B 2017/22097; A61B 2017/00349; A61B 17/3478; A61B 2017/3488; A61B 2090/0811; A61B 2090/3966; A61B 2017/00243; A61B 17/320016; A61F 2/2427; A61F 2/2463 (86) International application number: PCT/US2024/058862 (87) International publication number: WO 2025/128425 (19.06.2025 Gazette 2025/25)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: GE KH MA MD TN (30) Priority: 15.12.2023 US 202363610909 P (71) Applicant: Edwards Lifesciences Corporation Irvine, CA 92614 (US)	(72) Inventors: HAREL, Peleg 3079892 Caesarea (IL) PINHASOV, Dmitry 3079892 Caesarea (IL) ATIAS, Eitan 3079892 Caesarea (IL) WITZMAN, Ofir 3079892 Caesarea (IL) YAAKOBOVICH, Halit 3079892 Caesarea (IL) (74) Representative: Eisenführ Speiser  Patentanwälte Rechtsanwälte PartGmbB Gollierstraße 4 80339 München 80339 München (DE)